Skip to main content
Download PDF

Correction to: Melatonin and urological cancers: a new therapeutic approach

Cancer Cell International volume 20, Article number: 466 (2020) Cite this article

The Original Article was published on 10 September 2020

Correction to: Cancer Cell Int 20:444 (2020) https://doi.org/10.1186/s12935-020-01531-1

Following publication of the original article [1], we were notified of a mistake in the spelling of the first author.

  • Incorrect spelling: Mohammad Hossein Mehrzadi

  • Correct spelling: Mohammad Hossein Pourhanifeh

The original article has been corrected.

Reference

  1. Pourhanifeh MH, Hosseinzadeh A, Juybari KB, Mehrzadi S. Melatonin and urological cancers: a new therapeutic approach. Cancer Cell Int. 2020;20:444. https://doi.org/10.1186/s12935-020-01531-1.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran

    Mohammad Hossein Pourhanifeh

  2. Razi Drug Research, Center, Iran University of Medical Sciences, Tehran, Iran

    Azam Hosseinzadeh & Saeed Mehrzadi

  3. Department of Pharmacology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran

    Kobra Bahrampour Juybari

Authors
  1. Mohammad Hossein Pourhanifeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Azam Hosseinzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kobra Bahrampour Juybari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Saeed Mehrzadi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Saeed Mehrzadi.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pourhanifeh, M.H., Hosseinzadeh, A., Juybari, K.B. et al. Correction to: Melatonin and urological cancers: a new therapeutic approach. Cancer Cell Int 20, 466 (2020). https://doi.org/10.1186/s12935-020-01564-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12935-020-01564-6

Cancer Cell International

ISSN: 1475-2867

Contact us